84
Participants
Start Date
February 25, 2025
Primary Completion Date
December 19, 2025
Study Completion Date
June 30, 2026
UDP-003
The UDP-003 finished product is clear, colourless to yellow liquid that is intended to be a sterile solution for IV bolus push administration in sterile water at a concentration of 300 mg/mL.
Placebo
Placebo will be provided as a sterile clear, colourless solution formulated to match viscosity of the UDP-003 solution.
RECRUITING
CMAX Clinical Research, Adelaide
Lead Sponsor
Monash University
OTHER
Cyclarity Therapeutics, Inc.
INDUSTRY